{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:56:53Z","timestamp":1769605013286,"version":"3.49.0"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,13]]},"DOI":"10.18632\/oncotarget.11587","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T03:58:22Z","timestamp":1472097502000},"page":"58802-58812","source":"Crossref","is-referenced-by-count":10,"title":["Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model"],"prefix":"10.18632","volume":"7","author":[{"given":"Maowen","family":"Ba","sequence":"first","affiliation":[{"name":"Department of Neurology, Yantai Yuhuangding Hospital Affiliated to Qingdao Medical University, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yantaishan Hospital, Yantai City, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yantai Yuhuangding Hospital Affiliated to Qingdao Medical University, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoli","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Yuhuangding Hospital Affiliated to Qingdao Medical University, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ruijin Hospital Affiliated To Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bourdenx","year":"2015","journal-title":"Prog Neurobiol"},{"key":"2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","article-title":"Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment","volume":"83","author":"Robinson","year":"2007","journal-title":"Postgrad Med J"},{"key":"3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","article-title":"Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap","volume":"9","author":"Picconi","year":"2010","journal-title":"Lancet Neurol"},{"key":"4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biopha.2015.01.029","article-title":"Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies","volume":"70","author":"Deshmukh","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"5","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/mds.20459","article-title":"Pathophysiology of motor fluctuations in Parkinson's disease","volume":"20","author":"Widnell","year":"2005","journal-title":"Mov Disord"},{"key":"6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1468-1331.2002.00346.x","article-title":"The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications","volume":"9","author":"Przedborski","year":"2002","journal-title":"Eur J Neurol"},{"key":"7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1460-9568.1994.tb00584.x","article-title":"The role of pulsatilecontinuous dopamine receptor stimulation for functional recovery in Parkinson's disease","volume":"6","author":"Horowski","year":"1994","journal-title":"Eur J Neurosci"},{"key":"8","first-page":"S122","article-title":"Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications","volume":"47","author":"Oh","year":"2000","journal-title":"Ann Neurol"},{"key":"9","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","article-title":"Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism","volume":"23","author":"Oh","year":"2000","journal-title":"Trends Neurosci"},{"key":"10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40263-012-0016-z","article-title":"Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease","volume":"26","author":"Duty","year":"2012","journal-title":"CNS Drugs"},{"key":"11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2003.10.007","article-title":"Effect of a selective glutamate antagonist on L-dopa-induced dyskine\u00acsias in drug-na\u00efve parkinsonian monkeys","volume":"15","author":"B\u00e9dard","year":"2004","journal-title":"Neurobiol Dis"},{"key":"12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys","volume":"39","author":"Chase","year":"1996","journal-title":"Ann Neurol"},{"key":"13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.12.059","article-title":"NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model","volume":"282","author":"Qiu","year":"2015","journal-title":"Behav Brain Res"},{"key":"14","first-page":"199","article-title":"Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models","volume":"9","author":"Ma","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(98)01049-X","article-title":"Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration","volume":"813","author":"Chase","year":"1998","journal-title":"Brain Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expres\u00acsion, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Standaert","year":"2000","journal-title":"Mol Pharmacol"},{"key":"17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2004.03.011","article-title":"NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats","volume":"47","author":"Oh","year":"2004","journal-title":"Neuropharmacology"},{"key":"18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ncpneuro0530","article-title":"Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS","volume":"3","author":"Pascual-Leone","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neucli.2006.08.003","article-title":"Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation","volume":"36","author":"Lefaucheur","year":"2006","journal-title":"Neurophysiol Clin"},{"key":"20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNR.0b013e328335b411","article-title":"The effect of repetitive transcranial magnetic stimulation on a modelrat of Parkinson's disease","volume":"21","author":"Liu","year":"2010","journal-title":"Neuroreport"},{"key":"21","first-page":"561","article-title":"rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets","volume":"28","author":"Koch","year":"2010","journal-title":"Restor Neurol Neurosci"},{"key":"22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jocn.2013.11.025","article-title":"Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease","volume":"21","author":"Uzunel","year":"2014","journal-title":"J Clin Neurosci"},{"key":"23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.22348","article-title":"Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease","volume":"24","author":"Bhatia","year":"2009","journal-title":"Mov Disord"},{"key":"24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Brotchie","year":"1998","journal-title":"Exp Neurol"},{"key":"25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2003.08.013","article-title":"Effects of acute repetitive transcranial magnetic stimulation ondopamine release in the rat dorsolateral striatum","volume":"217","author":"Mano","year":"2004","journal-title":"J Neurol Sci"},{"key":"26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0028-3908(02)00069-2","article-title":"Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system","volume":"43","author":"Sillaber","year":"2002","journal-title":"Neuropharmacology"},{"key":"27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","article-title":"Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain","volume":"21","author":"Lee","year":"2001","journal-title":"J Chem Neuroanat"},{"key":"28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/PL00007744","article-title":"Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease","volume":"245","author":"Gash","year":"1998","journal-title":"J Neurol"},{"key":"29","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00001756-199807130-00039","article-title":"GDNF administration induces recovery of the nigrostriataldopaminergic system both in young and aged parkinsonian mice","volume":"9","author":"Ohmoto","year":"1998","journal-title":"Neuroreport"},{"key":"30","first-page":"129","article-title":"Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and inducesrecovery of function in a rat model of Parkinson's disease","volume":"82","author":"Bj\u00f6rklund","year":"1998","journal-title":"Neuroscience"},{"key":"31","first-page":"564095","article-title":"The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice","volume":"2015","author":"Wang","year":"2015","journal-title":"Parkinsons Dis"},{"key":"32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brainres.2013.08.051","article-title":"Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease","volume":"1537","author":"Cho","year":"2013","journal-title":"Brain Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/187152711797247821","article-title":"Is rTMS an effective therapeutic strategy that can be used to treat Parkinson's disease?","volume":"10","author":"Nardi","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.410220406","article-title":"Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies","volume":"22","author":"Chase","year":"1987","journal-title":"Ann Neurol"},{"key":"35","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Watson","year":"2007"},{"key":"36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","article-title":"Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration","volume":"662","author":"Chase","year":"1994","journal-title":"Brain Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Giuffrida","year":"2007","journal-title":"Exp Neurol"},{"key":"38","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.lfs.2005.08.001","article-title":"Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study","volume":"78","author":"Hu","year":"2006","journal-title":"Life Sci"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:44:29Z","timestamp":1749563069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,24]]},"references-count":38,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,9,13]]}},"alternative-id":["11587","27613848"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11587","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,24]]}}}